Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

Surgeons at Surya Hospitals performed India's first laser-assisted vulvectomy and clitorectomy for Vulvar Paget's Disease, a rare cancer. The procedure reduced blood loss, pain, and hospital stay, ...

Participants in the trial were all patients with tumors ranging from stage 1 to stage 3, meaning the tumors had not yet spread, the release indicated.

Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, ...

Emma Weston joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

A Stage 4 cancer survivor is grateful for a 'lifesaving' clinical trial, but experts are wary over potential federal funding ...

Dostarlimab offers hope in cancer treatment. Study shows tumour shrinkage in patients with mismatch repair defect. Some ...

A Silicon Valley company that makes life-saving technology got a rare chance to show off to one of the people it helped save ...

Learn how UC Davis’ Aggie Square is solving pressing challenges through collaborative research and cutting-edge technology.

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

First quarter 2025 revenues of $3.0 billion; GAAP diluted EPS of $7.27 and non-GAAP diluted EPS(a) of $8.22First quarter 2025 Dupixent® global net sales (recorded by Sanofi) increased 19% to $3.67 bil ...